darunavir eg 800 mg film-coat. tabl.
eg sa-nv - darunavir 800 mg - film-coated tablet - 800 mg - darunavir 800 mg - darunavir
darunavir sandoz 150 mg film-coat. tabl.
sandoz sa-nv - darunavir 150 mg - film-coated tablet - 150 mg - darunavir 150 mg - darunavir
darunavir sandoz 75 mg film-coat. tabl.
sandoz sa-nv - darunavir 75 mg - film-coated tablet - 75 mg - darunavir 75 mg - darunavir
darunavir sandoz 300 mg film-coat. tabl.
sandoz sa-nv - darunavir 300 mg - film-coated tablet - 300 mg - darunavir 300 mg - darunavir
darunavir sandoz 400 mg film-coat. tabl.
sandoz sa-nv - darunavir 400 mg - film-coated tablet - 400 mg - darunavir 400 mg - darunavir
darunavir sandoz 600 mg film-coat. tabl.
sandoz sa-nv - darunavir 600 mg - film-coated tablet - 600 mg - darunavir 600 mg - darunavir
darunavir sandoz 800 mg film-coat. tabl.
sandoz sa-nv - darunavir 800 mg - film-coated tablet - 800 mg - darunavir 800 mg - darunavir
darunavir and ritonavir tablets 400 mg/50 mg 400 mg + 50 mg oral solid ordinary tablets
hetero labs ltd - darunavir ethanolate + ritonavir - oral solid ordinary tablets - 400 mg + 50 mg
darunavir tablets 600 mg oral solid ordinary film-coated tablets
cipla ltd. - darunavir ethanolate - oral solid ordinary film-coated tablets - 600 mg
darunavir tablet, film coated
teva pharmaceuticals, inc. - darunavir hydrate (unii: kpc4nrb25l) (darunavir - unii:yo603y8113) - darunavir tablets, co-administered with ritonavir (darunavir/ritonavir), in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection in adult and pediatric patients 3 years of age and older [see use in specific populations (8.4) and clinical studies (14)]. co-administration of darunavir/ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (narrow therapeutic index). examples of these drugs and other contraindicated drugs (which may lead to reduced efficacy of darunavir) are listed below [see drug interactions (7.3)] . due to the need for co-administration of darunavir with ritonavir, please refer to ritonavir prescribing information for a description of ritonavir contraindications. - alpha 1-adrenoreceptor antagonist: alfuzosin - anti-gout: colchicine, in patients with renal and/or hepatic impairment -